Adicet Bio’s (ACET) Neutral Rating Reaffirmed at HC Wainwright
HC Wainwright reissued their neutral rating on shares of Adicet Bio (NASDAQ:ACET – Free Report) in a report published on Thursday,Benzinga reports. A number of other research firms have also commented on ACET. Wedbush reiterated an “outperform” rating and set a $5.00 price target on shares of Adicet Bio in a report on Thursday, November […]
